Oncology News and Research RSS Feed - Oncology News and Research Twitter

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.
Current x-ray- examinations capture only 20% of lung cancer cases

Current x-ray- examinations capture only 20% of lung cancer cases

Each year, nearly 3000 Norwegians develop lung cancer. Current x-ray- examinations capture only 20 percent of cases. With modern ultralow-dose CT, the radiologists hit the bull's eye 90 per cent of the time. [More]
Researchers find why certain glioblastomas become drug resistance

Researchers find why certain glioblastomas become drug resistance

Researchers at the University of California, San Diego School of Medicine have found one of the keys to why certain glioblastomas - the primary form of a deadly brain cancer - are resistant to drug therapy. [More]
Cilag GmbH International acquires biopharmaceutical company, Covagen AG

Cilag GmbH International acquires biopharmaceutical company, Covagen AG

Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has acquired Covagen AG, a privately-held, biopharmaceutical company specializing in the development of multispecific protein therapeutics through the FynomAb® technology platform. [More]
Statistical genetic analysis can detect aggressiveness of lymphoma

Statistical genetic analysis can detect aggressiveness of lymphoma

Each year, more than one thousand Norwegians develop lymphoma. A statistical genetic analysis can detect when the disease will be aggressive. Thereby, treatment can be initiated in time. [More]
Researchers examine impact of BIM deletion on survival outcomes of advanced NSCLC patients

Researchers examine impact of BIM deletion on survival outcomes of advanced NSCLC patients

Bcl-2-like protein 11 (BIM) deletion in advanced non-small cell lung cancer (NSCLC) is associated with shorter progression free survival (PFS) in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) or chemotherapy treated Asian patients. [More]
Health insurance reimbursement may determine cancer screening rates

Health insurance reimbursement may determine cancer screening rates

A study published today indicates that people living in American states that offer higher Medicaid payments for office visits are more likely to have been screened for breast, cervical, and colorectal cancers than those in states giving lower levels of Medicaid support. [More]
ProMedica participates in innovative research into development of non-invasive treatment for BPH

ProMedica participates in innovative research into development of non-invasive treatment for BPH

ProMedica is participating in innovative research into the development of a safe, non-invasive treatment for BPH or enlarged prostate. BPH can block the flow of urine out of the bladder and cause bladder, urinary tract or kidney problems. [More]
ESMO announces names of outstanding individuals receiving annual awards

ESMO announces names of outstanding individuals receiving annual awards

The European Society for Medical Oncology, the leading pan-European organisation representing medical oncologists, announced the names of outstanding individuals receiving the Society's esteemed annual awards, to be presented during the ESMO 2014 Congress, on 26 September, in Madrid. [More]
ZERO hosts 16 run/walk events to raise funds, awareness to end prostate cancer

ZERO hosts 16 run/walk events to raise funds, awareness to end prostate cancer

ZERO – The End of Prostate Cancer is hosting 16 run/walk events across the nation during September, Prostate Cancer Awareness Month, to raise funds and awareness to end prostate cancer, a disease that affects one in seven American men. [More]
Eisai pleased to support CEA comic book that educates kids and parents about epilepsy

Eisai pleased to support CEA comic book that educates kids and parents about epilepsy

Eisai Limited is pleased to support the Canadian Epilepsy Alliance (CEA) in the introduction of the first-of-its-kind comic book available in Canada. [More]
Erlotinib feasible in KRAS wild-type lung adenocarcinoma

Erlotinib feasible in KRAS wild-type lung adenocarcinoma

Erlotinib is a valid treatment option for patients with KRAS wild-type lung adenocarcinoma refractory to chemotherapy, study data show. [More]
EGFR biomarkers predict NSCLC response to vandetanib

EGFR biomarkers predict NSCLC response to vandetanib

Biomarker analyses of tumour samples from the ZODIAC study indicate that epidermal growth factor receptor gene copy number and mutation status may help identify the non-small-cell lung cancer patients most likely to benefit from treatment with vandetanib plus docetaxel. [More]
Cigna HealthCare, NCH team up to deliver quality care related to cancer

Cigna HealthCare, NCH team up to deliver quality care related to cancer

New Century Health (NCH) and Cigna HealthCare of Arizona today announced an alliance focused on delivering quality care related to cancer. Cigna customers covered under Arizona Medicare Advantage plans who receive care through the Cigna Medical Group (CMG) are included in this new program with NCH. [More]
Glenmark announces discovery and initiation of IND enabling studies of innovative bispecific antibody

Glenmark announces discovery and initiation of IND enabling studies of innovative bispecific antibody

Glenmark Pharmaceuticals S.A. (GPSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Limited India (GPL), announces the discovery and initiation of IND enabling studies of a novel clinical development candidate, GBR 1302, a HER2xCD3 bispecific antibody. [More]
Study explores the effectiveness of stents in treating vein obstructions

Study explores the effectiveness of stents in treating vein obstructions

Jobst Vascular Institute is conducting pioneering research that looks at using stents to treat blocked veins. For years, stents - small mesh tubes - have been used to treat narrowed or blocked arteries; however none are specifically designed for use in veins. [More]
New web-based program helps to determine deadly form of brain cancer

New web-based program helps to determine deadly form of brain cancer

A new web-based program developed by University of Kentucky Markey Cancer Center researchers will provide a simple, free way for healthcare providers to determine which brain tumor cases require testing for a genetic mutation. [More]
Research validates Myc inhibition as effective therapeutic strategy for glioma

Research validates Myc inhibition as effective therapeutic strategy for glioma

Research led by the Vall d'Hebron Institute of Oncology (VHIO) evidence the most conclusive preclinical results to-date validating Myc inhibition as a therapeutic strategy in glioma - a highly agressive tumor type that notoriously outsmarts current anti-cancer therapies. [More]
Researchers validate criteria that predicts early menopause in young cancer survivors

Researchers validate criteria that predicts early menopause in young cancer survivors

Girls with cancer who are most likely to become infertile after treatment can be identified using guidelines developed almost 20 years ago, new research shows. [More]
Lymphocyte count predicts papillary RCC patient survival

Lymphocyte count predicts papillary RCC patient survival

Lymphopenia is a significant predictor of outcome in patients undergoing surgery for papillary renal cell carcinoma, US researchers report. [More]
Physical activity fails to show link with chronic musculoskeletal pain

Physical activity fails to show link with chronic musculoskeletal pain

Neither little nor excessive physical activity contributes to chronic musculoskeletal pain in people who are middle-aged or older, Japanese study findings suggest. [More]